Maia Biotechnology earnings were -$16.2M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest MAIA earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$5.3M, up 18.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MAIA reported annual earnings of -$23.3M, with 17.6% growth. The next MAIA earnings date is Nov 4, 2025.
What were Maia Biotechnology's earnings last quarter?
On MAIA's earnings call on Invalid Date, Maia Biotechnology (NYSEMKT: MAIA) reported Q2 2025 earnings per share (EPS) of -$0.18, up 55% year over year. Total MAIA earnings for the quarter were -$5.35 million. In the same quarter last year, Maia Biotechnology's earnings per share (EPS) was -$0.40.
The next MAIA earnings call is Invalid Date. Add MAIA to your watchlist to be reminded of Maia Biotechnology's next earnings date.
Is Maia Biotechnology profitable or losing money?
As of the last Maia Biotechnology earnings report, Maia Biotechnology is currently losing money. Maia Biotechnology's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$16.17 million, a 42.41% decrease year over year.
What was MAIA's earnings growth in the past year?
As of Maia Biotechnology's earnings date in Invalid Date, Maia Biotechnology's earnings has grown year over year. MAIA earnings in the past year totalled -$16.17 million.
What are Maia Biotechnology's earnings expectations?
The current EPS estimate for Maia Biotechnology's earnings report in Invalid Date is -$0.19.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.